Cardiac damage and tropism of severe acute respiratory syndrome coronavirus 2

• Verfasst von: Tangos, Melina [VerfasserIn]
• Verfasst von: Jarkas, Muhammad [VerfasserIn]
• Verfasst von: Akın, Ibrahim [VerfasserIn]
• Verfasst von: El-Battrawy, Ibrahim [VerfasserIn]
• Verfasst von: Hamdani, Nazha [VerfasserIn]
• Titel: Cardiac damage and tropism of severe acute respiratory syndrome coronavirus 2
• Verf.angabe: Melina Tangos, Muhammad Jarkas, Ibrahim Akin, Ibrahim El-Battrawy and Nazha Hamdani
• E-Jahr: 2024
• Jahr: April 2024
• Umfang: 9 S.
• Illustrationen: Illustrationen
• Fussnoten: Online verfügbar: 23. Februar 2024, Artikelversion: 23. Februar 2024 ; Gesehen am 03.02.2025
• Titel Quelle: Enthalten in: Current opinion in microbiology
• Ort Quelle: London : Current Biology Ltd., 1998
• Jahr Quelle: 2024
• Band/Heft Quelle: 78(2024) vom: Apr., Artikel-ID 102437, Seite 1-9
• ISSN Quelle: 1879-0364
• DOI: doi:10.1016/j.mib.2024.102437
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1916191614

Abstract

Until now, the World Health Organization registered over 771 million cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection worldwide, of which 6.97 million resulted in death. Virus-related cardiovascular events and pre-existing heart problems have been identified as major contributing factors to global infection-related morbidity and mortality, emphasizing the necessity for risk assessment and future prevention. In this review, we highlight cardiac manifestations that might arise from an infection with SARS-CoV-2 and provide an overview of known comorbidities that worsen the outcome. Additionally, we aim to summarize the therapeutic strategies proposed to reverse virus-associated myocardial damage, which will be further highlighted in this review, with an outlook to successful recovery and prevention.